Pharmacoepidemiological Study of the Impact of Roactemra Treatment on Fatigue in Rheumatoid Arthritis Patients in a Real Life Setting
Phase of Trial: Phase IV
Latest Information Update: 17 Jun 2017
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms PEPS
- Sponsors Roche
- 17 Jun 2017 Results of pooled analysis (n=1494) of three observational studies (PEPS, Spare-1 and Act-solo), presented at the 18th Annual Congress of the European League Against Rheumatism.
- 07 Sep 2015 Results published in the Clinical and Experimental Rheumatology.
- 16 Mar 2012 Actual number of patients changed from 387 to 719 as reported by ClinicalTrials.gov.